Labcyte, Inc.

62 articles about Labcyte, Inc.

• Collaboration of Four Biotech Companies Showcases High Throughput DNA Assembly Platform for Diverse Applications

  5/23/2019

  The companies plan to host an event at Arzeda's headquarters in Seattle on Thursday, May 30th where they will demonstrate several tangible examples of how the integrated platform accelerated development of various products including a food and beverage sweetener as well as a key component in the next generation of plexiglass.

• Beckman Coulter Life Sciences Acquires Labcyte To Expand Laboratory Automation Business

  1/30/2019

  Beckman Coulter Life Sciences today announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California.

• Labcyte Introduces the Echo 650 and 655 Liquid Handlers

  10/16/2018

  New systems include features recently launched with the award-winning 650T and 655T models

• Labcyte to Support GP-write Project Under New Agreement With Center of Excellence for Engineering Biology

  7/17/2018

  Researchers Will Receive Preferred Pricing and Early Access to New Technologies for Understanding the Blueprint for Life Provided by the Human Genome Project

• Labcyte Reaches Agreement With Merck to Supply Acoustic-Mass Spectrometry Equipment

  4/17/2018

  Acoustic droplet ejection technology uses the gentle energy of sound waves to move liquids at nanoliter resolution with superior precision and accuracy.

• Labcyte Launches New Family of Echo Acoustic Liquid Handlers Featuring 21 CFR Part 11 Compliance Software

  2/5/2018

  Labcyte, Inc. today announced the release of a regulatory-ready family of Echo Acoustic Liquid Handlers intended for pharmaceutical companies and laboratories developing and running bioassays.

• Labcyte Introduces New Acoustic Sample Management Solution

  2/5/2018

  Labcyte Inc. today launched the Access Dual-Robot System (DRS) and the Echo 655T Liquid Handler, key components of a new acoustic sample management solution that will support the next generation of pharmaceutical drug discovery as it demands faster, high-throughput screens while requiring less sample.

• Labcyte and FIMM Extend Personalized Medicine Collaboration

  11/8/2017

  Labcyte and the Institute for Molecular Medicine Finland announced they are extending their personalized medicine collaboration to include multiple new applications that leverage the unique capabilities of Labcyte’s Echo liquid handler and Access™ automation platform.

• GlaxoSmithKline, AstraZeneca PLC And Labcyte Inc. Form Alliance To Develop Acoustic Mass Spectrometry - A Novel Sample Handling Technology For MS-Based Drug Discovery

  9/20/2017

• Labcyte Inc. Introduces New 384-Well Low Dead Volume Microplate For Echo 525 Liquid Handlers

  9/14/2017

• Labcyte Inc. Moves Global Headquarters To 60,000 Square Foot Building In San Jose

  6/1/2017

• Labcyte Inc. Announces Collaboration With Notable Labs To Apply Functional Cancer Cell Screening To Help Clinicians Individualize Patient Care

  12/7/2016

• Labcyte Inc. Announces Partnership With AstraZeneca PLC To Develop New Fully Acoustic Liquid Handling System For Drug Screening

  11/20/2015

• Labcyte Inc. Introduces Echo Combination Screen Software For Its Acoustic Liquid Handlers

  9/10/2015

• Labcyte Inc. And FIMM Extend Collaboration To Bring Real-Time Personalized Medicine To Cancer Treatments

  6/11/2015

• Labcyte Inc. Introduces Reservoir Plate For Echo 525 Liquid Handler To Facilitate High-Throughput, Large Volume Reagent Transfers For Genomic, Proteomic And Cell-Based Assays

  5/28/2015

• Oxford Finance And Silicon Valley Bank Close $17 Million Debt Facility With Labcyte Inc.

  5/6/2015

• Labcyte Inc. Congratulates AstraZeneca PLC’s Jonathan Wingfield, Winner Of The 2015 SLAS Innovation Award

  4/29/2015

• Labcyte Inc. Commends Institute For Molecular Medicine Finland – Pfizer Leukemia Study Results

  2/10/2015

• Labcyte Inc. Names Chris Grimley As Vice President Of Marketing

  2/9/2015